Clinical Trial Update: Irinotecan Liposome，Albumin Paclitaxel and Gemcitabine First-line Treatment for Pancreatic Cancer [Phase 1, Phase 2]

View source ↗

Summary

This clinical trial entry describes a Phase 1/Phase 2 study evaluating a three-drug first-line regimen (irinotecan liposome, albumin-bound paclitaxel, and gemci…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pancreatic Cancer

Drugs mentioned

• Abraxane (paclitaxel albumin-bound)
• Gemzar (gemcitabine)
• Irinotecan liposome (liposomal irinotecan)

Snippet

Sponsor: Harbin Medical University | Conditions: Pancreatic Cancer | Phase 1, Phase 2 | Status: NOT_YET_RECRUITING